Cross Country (CCRN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Cross Country Healthcare (CCRN) reported $309.94 million in revenue for the quarter ended December 2024, representing a year-over-year decline of 25.1%. EPS of $0.04 for the same period compares to $0.29 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $306.2 million, representing a surprise of +1.22%. The company delivered an EPS surprise of -63.64%, with the consensus EPS estimate being $0.11.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Cross Country performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Nurse and allied staffing statistical data - FTEsn: 7,621 versus the two-analyst average estimate of 7,441. Physician staffing statistical data - Revenue per day filled: $2,085 versus the two-analyst average estimate of $1,910. Physician staffing statistical data - Days filled in HRS: 25,427 versus 19,207 estimated by two analysts on average. Revenue- Physician staffing: $53.01 million versus $51.59 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +13.1% change. Revenue- Nurse and allied staffing: $256.93 million versus the four-analyst average estimate of $254.81 million. The reported number represents a year-over-year change of -30%. View all Key Company Metrics for Cross Country here>>>Shares of Cross Country have returned -7.5% over the past month versus the Zacks S&P 500 composite's -3.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cross Country Healthcare, Inc. (CCRN): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks